Latest Technology News

McLaren Minerals has reported exceptional high-grade assay results from its 2025 Phase 1 drilling program, revealing new mineralised sequences and underpinning a significant resource upgrade at its McLaren Titanium Project in Western Australia.

333D Ltd reports a fifth consecutive quarter of revenue growth, secures $1 million in fresh capital, and expands its blockchain healthcare initiatives while building a strategic Bitcoin treasury.

Blaze Minerals has reported outstanding channel sample results for critical metals gallium and germanium at its Loulombo Project in the Republic of the Congo, setting the stage for an imminent reverse circulation drilling campaign.

Kuniko Limited has secured new funding and is poised to commence drilling at its Commonwealth Gold-Silver Project in New South Wales, targeting district-scale precious metals in a Tier-1 jurisdiction.

Catapult Sports has successfully completed a A$130 million institutional placement to fund its strategic acquisition of IMPECT GmbH, a leader in soccer analytics software. The company also launched a A$20 million Share Purchase Plan to engage existing shareholders.

Aussie Broadband reported robust FY25 results with nearly $1.2 billion revenue and signed a transformative six-year wholesale agreement, setting the stage for ambitious growth through FY28.

Clarity Pharmaceuticals’ Co-PSMA Phase II trial shows its Cu-SAR-bisPSMA diagnostic agent detects more prostate cancer lesions than current standard imaging, promising earlier and more accurate recurrence detection.

Zeotech Limited has signed a non-binding MOU with Cement Australia to collaborate on advancing AusPozz™, a high-reactivity metakaolin product aimed at reducing carbon emissions in concrete production.

Altech Batteries has raised $6 million through a share placement to accelerate development and commercialisation of its innovative battery technologies, including the CERENERGY solid-state battery and Silumina Anodes.

Resouro Strategic Metals is on track to close its non-brokered private placement within the week, aiming to fund critical engineering work for its Tiros Titanium-Rare Earths Project in Brazil.

EMVision Medical Devices has received a $3 million government grant to fund a clinical study demonstrating its emu™ brain scanner's impact on accelerating stroke diagnosis in rural emergency departments.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.